Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment.
Jinyong KimEuijin ChangSong Yi ParkDae-Won LeeChang Kyung KangPyeong Gyun ChoeNam Joong KimMyoung-Don OhWan Beom ParkKyung-Hun LeeSeock-Ah ImPublished in: The oncologist (2022)
Our study emphasizes the importance of the personalized risk stratification and consideration for booster doses in more vulnerable populations.